Psychopharmacology and Psychiatry Updates

A podcast by Psychopharmacology Institute

Categorie:

213 Episodio

  1. Acute Agitation and Dexmedetomidine: A Novel Treatment Approach

    Pubblicato: 30/8/2023
  2. The Prevalence and Risks of RBD

    Pubblicato: 25/8/2023
  3. ADHD Medication and Their Role in Anxiety and Depression

    Pubblicato: 20/8/2023
  4. In the Realm of Sleep: RBD Diagnosis Explained

    Pubblicato: 15/8/2023
  5. NAC in Schizophrenia: Pie in the Sky or Groundbreaking Solution?

    Pubblicato: 10/8/2023
  6. Child Psychiatry: NAC and SAMe

    Pubblicato: 5/8/2023
  7. Youth Psychotropic Prescription Trends: Pandemic Influence

    Pubblicato: 31/7/2023
  8. Nature's Remedies in Youth: St. John's Wort and Valerian

    Pubblicato: 26/7/2023
  9. Exploring Serotonergic Antidepressants for PMDD

    Pubblicato: 21/7/2023
  10. Exploring Omega-3's Role in Child Psychiatry

    Pubblicato: 16/7/2023
  11. ADHD Meds for Preschoolers: Lisdexamfetamine

    Pubblicato: 11/7/2023
  12. Using Ginkgo Biloba in Children

    Pubblicato: 6/7/2023
  13. Examining COVID's Lasting Effects in Psychiatry

    Pubblicato: 1/7/2023
  14. Beyond SSRIs: Antipsychotic Augmentation in OCD

    Pubblicato: 26/6/2023
  15. Overcoming Barriers to Metabolic Monitoring in Youth Treated With SGAs

    Pubblicato: 21/6/2023
  16. Exploring Outcomes and Strategies in OCD Treatment After the First Trial

    Pubblicato: 16/6/2023
  17. Diving Into the APA Annual Meeting: Highlights and Insights!

    Pubblicato: 11/6/2023
  18. Exploring the Intriguing World of Microdosing Psilocybin

    Pubblicato: 6/6/2023
  19. SSRIs for OCD: A Closer Look at First-Line Treatment

    Pubblicato: 1/6/2023
  20. Exploring Nonstimulant Treatments for ADHD

    Pubblicato: 27/5/2023

4 / 11

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site